¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ ICKMDS(International Conference of Korean Movement Disorder Society) 2023 (1ÀÏÂ÷) : 2023-12-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ ICKMDS(International Conference of Korean Movement Disorder Society) 2023 (1ÀÏÂ÷) : 2023-12-01
±³À°ÀÏÀÚ : 2023-12-01
±³À°Àå¼Ò : BEXCO ÄÁº¥¼ÇȦ 1,2Ãþ

±³À°ÁÖÁ¦ : ICKMDS(International Conference of Korean Movement Disorder Society) 2023 (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : Ãֹ̼Ò
¿¬¶ôó : 02-6395-2876  

À̸ÞÀÏ : movement@kmds.or.kr

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í 1. »çÀüµî·Ï : Àü¹®ÀÇ 200,000¿ø / Àü°øÀÇ 100,000¿ø / Çлý,°£È£»ç(¿¬±¸),±â»ç µî 70,000¿ø, µ¿¹ÝÀÚ 50,000¿ø  2. ÇöÀåµî·Ï : Àü¹®ÀÇ 250,000¿ø / Àü°øÀÇ 150,000¿ø Çлý,°£È£»ç(¿¬±¸),±â»ç µî 80,000¿ø, µ¿¹ÝÀÚ 60,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 12¿ù 01ÀÏ Room A 08:30~10:00 Plenary Session 1. Therapeutic Innovation in Movement Disorders Àü¹ü¼®/Victor Fung(¼­¿ïÀÇ´ë/The University of Sydney, Australia)

±³À°½Ã°£ 12¿ù 01ÀÏ Room A 08:30~08:55 Cell Replacement Therapies in Parkinson¡¯s Disease ±èÀåȯ(Çѱ¹»ý¸í°øÇבּ¸¿ø)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 08:55~09:20 Direct Convective Perfusion for Gene Therapy for Neurologic Disorders Russell Lonser(The Ohio State University, USA)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 09:20~09:45 Microbiome-based Therapeutics for Parkinson Ai Huey Tan(Universiti Malaya, Malaysia)

Åä·Ð 12¿ù 01ÀÏ Room 1 09:45~10:00 Q&A ()

ÈÞ½Ä 12¿ù 01ÀÏ Room 1 10:00~10:20 Break ()

±âŸ 12¿ù 01ÀÏ Room 1 10:20~11:50 Plenary Session 2. Alpha-synuclein ±èÀ±Áß/Hideki Mochizuki(¿¬¼¼ÀÇ´ë/Osaka University, Japan)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 10:20~10:45 Using Alpha-synuclein Propagation to Predict Disease Trajectory: Seeding is Believing Kelvin C Luk(University of Pennsylvania, USA)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 10:45~11:10 Role of Neuroinflammation in Developing Compound Proteinopathies À̽ÂÀç(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 11:10~11:35 Imaging ¥á-synuclein pathologies in Parkinson¡¯s disease and related disorders Makoto Higuchi(National Institutes for Quantum Science and Technology, Japan)

Åä·Ð 12¿ù 01ÀÏ Room 1 11:35~11:50 Q&A ()

½Ä»ç 12¿ù 01ÀÏ Room 1 11:50~13:00 Lunch ()

±âŸ 12¿ù 01ÀÏ Room 1 13:00~14:30 Plenary Session 3. Non-invasive Treatment in Movement Disorders ±èÈñÅÂ/Shen-Yang Lim(ÇѾçÀÇ´ë/Universiti Malaya, Malaysia)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 13:00~13:25 Repetitive Transcranial Magnetic Stimulation Masashi Hamada(The University of Tokyo, Japan)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 13:25~13:50 Peripheral Nerve/Muscle Stimulation in Movement Disorders Hrishikesh Kumar(Institute of Neuroscience Kolkata, India)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 13:50~14:15 Transcranial Direct Current Stimulation for Treatment of Movement Disorders ¹ÚÁ¤ÀÌ(µ¿±¹ÀÇ´ë)

Åä·Ð 12¿ù 01ÀÏ Room 1 14:15~14:30 Q&A ()

ÈÞ½Ä 12¿ù 01ÀÏ Room 1 14:30~14:50 Break ()

±âŸ 12¿ù 01ÀÏ Room 1 14:50~16:00 Parallel Session 1. Biomarkers in Movement Disorders ¾ÈŹü/Nobutaka Hattori(°æÈñÀÇ´ë/Juntendo University, Japan)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 14:50~15:10 Seed Amplification Assay for Movement Disorders ÃÖ¿µÇ¥(Çѱ¹³ú¿¬±¸¿ø)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 15:10~15:30 Fluid Biomarker in Parkinsonism Nobutaka Hattori(Juntendo University, Japan)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 15:30~15:50 Electrophysiologic Biomarker for Dystonia ¿ÀÀÀ¼®(Ãæ³²ÀÇ´ë)

Åä·Ð 12¿ù 01ÀÏ Room 1 15:50~16:00 Q&A ()

ÈÞ½Ä 12¿ù 01ÀÏ Room 1 16:00~16:20 Break ()

±âŸ 12¿ù 01ÀÏ Room 1 16:20~17:30 Parallel Session 2. Gait Analysis in Parkinson ¸¶È¿ÀÏ/Simon Lewis(ÇѸ²ÀÇ´ë/University of Sydney, Australia)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 16:20~16:40 Clinical Gait Features in PD: from Prodromal to Advanced Simon Lewis(University of Sydney, Australia)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 16:40~17:00 Current Status of Gait Analysis ¹ÚÁ¤È£(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 12¿ù 01ÀÏ Room 1 17:00~17:20 Gait Analysis: Future Directions Laurie King(Oregon Health & Science University, USA)

Åä·Ð 12¿ù 01ÀÏ Room 1 17:20~17:30 Q&A ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ ICKMDS(International Conference of Korean Movement Disorder Society) 2023 (1ÀÏÂ÷) : 2023-12-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÆó¾ÏÇÐȸ 2023 KALC International Conference-2ÀÏÂ÷ : 2023-12-01
´ÙÀ½±Û ´ëÇÑÅëÁõÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2023-12-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 8 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 3 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷